Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Rating, Dietz [VerfasserIn]   i
 Wolf, Christian [VerfasserIn]   i
 Bast, Thomas [VerfasserIn]   i
Titel:Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes
Titelzusatz:a 6-month randomized, double-blind, placebo-controlled study
Verf.angabe:Dietz Rating, Christian Wolf, Thomas Bast
Jahr:2000
Umfang:5 S.
Teil:volume:41
 year:2000
 number:10
 pages:1284-1288
 extent:5
Fussnoten:First published: 05 November 2007 ; Gesehen am 18.01.2021
Titel Quelle:Enthalten in: Epilepsia
Ort Quelle:Oxford [u.a.] : Wiley-Blackwell, 1909
Jahr Quelle:2000
Band/Heft Quelle:41(2000), 10, Seite 1284-1288
ISSN Quelle:1528-1167
Abstract:Purpose: To evaluate the efficacy and tolerability of sulthiame (STM) as monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Methods: Sixty-six BECTS patients entered a 6-month double-blind trial and were randomized to receive either STM (5 mg/kg/day) or a placebo. All patients had had two or more seizures during the 6 months preceding the trial and were aged 3-11 years. Seizures were recorded by parents in a diary. STM plasma levels and electroencephalograms (EEGs) were overseen by patient-blinded observers. The primary effectiveness variable was the rate of treatment failure events (TFEs) per group. TFEs consisted of a first seizure after a 7-day run-in period, intolerable adverse events (AEs), development of another epileptic syndrome, or termination of the trial by parents or patient. Results: Twenty-five of the 31 STM-treated patients (81%) and 10 of the 35 placebo-treated patients (29%) completed the trial without any TFEs (p = 0.00002). Most TFEs were seizures (n = 4 for the STM patients, n = 21 for the placebo group). Parents requested termination for two placebo-treated patients. Four patients were terminated for administrative reasons. No patient was withdrawn for AEs. While all patients displayed at least one specific focus in either the awake or asleep EEG initially, 11 STM-treated patients had a normal awake EEG and 10 had a normal asleep one after 6 months. Conclusions: STM was remarkably effective in preventing seizures in patients with BECTS. Patients suffering from ≥2 seizures during the past 6 months had a high risk of early recidivism. STM was well tolerated and should be considered for children with BECTS who are in need of treatment.
DOI:doi:10.1111/j.1528-1157.2000.tb04606.x
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/https://doi.org/10.1111/j.1528-1157.2000.tb04606.x
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1528-1157.2000.tb04606.x
 DOI: https://doi.org/10.1111/j.1528-1157.2000.tb04606.x
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Centrotemporal spikes
 EEG.
 Epilepsy
 Pediatric
 Sulthiame
K10plus-PPN:174488742X
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68680804   QR-Code
zum Seitenanfang